{"id":"hbv-vaccination","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site pain, redness, or swelling"},{"rate":"1-6","effect":"Fever"},{"rate":"5-15","effect":"Fatigue or malaise"},{"rate":"3-10","effect":"Headache"},{"rate":"2-8","effect":"Myalgia"}]},"_chembl":{"chemblId":"CHEMBL5917849","moleculeType":null,"molecularWeight":"445.93"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains hepatitis B surface antigen (HBsAg), typically produced via recombinant DNA technology, which triggers both humoral (antibody) and cell-mediated immune responses. This priming of the adaptive immune system enables rapid recognition and neutralization of the virus upon exposure, preventing establishment of infection and chronic hepatitis B.","oneSentence":"HBV vaccination stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus antigens, preventing infection and chronic disease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:22:45.244Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis B virus infection in infants, children, and adults"},{"name":"Post-exposure prophylaxis in non-immune individuals exposed to HBV"}]},"trialDetails":[{"nctId":"NCT04804072","phase":"NA","title":"INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2021-06-02","conditions":"HIV Infections, Drug Use, Opioid Use","enrollment":447},{"nctId":"NCT06507605","phase":"PHASE1","title":"Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2024-08-30","conditions":"Prevention of Malaria Transmission and Clinical Malaria","enrollment":240},{"nctId":"NCT07160244","phase":"PHASE3","title":"BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-08-25","conditions":"Healthy","enrollment":6000},{"nctId":"NCT06786429","phase":"PHASE4","title":"Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.","status":"NOT_YET_RECRUITING","sponsor":"Eunice Dube","startDate":"2026-08-30","conditions":"Hepatitis B, Human Papilloma Virus, Gall Stones (& [Calculus - Gall Bladder])","enrollment":1800},{"nctId":"NCT04294433","phase":"PHASE4","title":"Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children","status":"COMPLETED","sponsor":"Laval University","startDate":"2018-06-11","conditions":"Hepatitis B","enrollment":431},{"nctId":"NCT07346508","phase":"NA","title":"Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol","status":"NOT_YET_RECRUITING","sponsor":"KC Care Health Center","startDate":"2026-04-01","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":250},{"nctId":"NCT04327440","phase":"","title":"RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi","status":"COMPLETED","sponsor":"Michigan State University","startDate":"2020-02-04","conditions":"Malaria, Malaria Vaccine, Insecticide-treated Bednets","enrollment":1691},{"nctId":"NCT07328711","phase":"EARLY_PHASE1","title":"Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-01-01","conditions":"Chronic Hepaititis B","enrollment":132},{"nctId":"NCT06624176","phase":"NA","title":"ShotBlocker During Intramuscular Injection Randomized Control Trial","status":"RECRUITING","sponsor":"Lauren Fortier","startDate":"2024-01-10","conditions":"Neonatal Pain","enrollment":200},{"nctId":"NCT07320716","phase":"PHASE2","title":"Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children","status":"NOT_YET_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2026-01-02","conditions":"Diarrhoea","enrollment":528},{"nctId":"NCT06901362","phase":"","title":"Seroprevalence and Vaccination Rate of Hepatitis B Virus and Varicella-zoster Virus Among Medical Students Under Immunizing Program","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2025-04-01","conditions":"Healthy, Healthy Adult","enrollment":401},{"nctId":"NCT04674462","phase":"PHASE4","title":"Understanding Poor Vaccine Responses to Hepatitis B Vaccination","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-07-07","conditions":"Vaccine Reaction","enrollment":101},{"nctId":"NCT05073003","phase":"PHASE1","title":"A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-10-06","conditions":"Diarrhoea","enrollment":551},{"nctId":"NCT03910972","phase":"PHASE1, PHASE2","title":"Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2019-10-07","conditions":"Schistosomiasis, Schistosoma Mansoni","enrollment":290},{"nctId":"NCT04843852","phase":"PHASE1","title":"TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2025-10-16","conditions":"Hepatitis B, Chronic Hepatitis B","enrollment":10},{"nctId":"NCT07185152","phase":"NA","title":"The Effect of Mechanical Vibration and Flick Tapping Methods in Reducing Pain in Infant Vaccination","status":"COMPLETED","sponsor":"Berrin GOGER","startDate":"2024-04-29","conditions":"Health Knowledge, Attitudes, Practice, Health Behavior","enrollment":80},{"nctId":"NCT05155579","phase":"PHASE1","title":"Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-05-14","conditions":"Malaria","enrollment":593},{"nctId":"NCT06038617","phase":"PHASE4","title":"Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-10-30","conditions":"Fever After Vaccination, Fever, Seizures Fever","enrollment":344},{"nctId":"NCT07126041","phase":"NA","title":"Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)","status":"NOT_YET_RECRUITING","sponsor":"Oxford University Clinical Research Unit Indonesia","startDate":"2025-08-14","conditions":"Pregnancy, Neonatal Mortality, Tuberculosis","enrollment":1750000},{"nctId":"NCT04297917","phase":"PHASE1","title":"First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection","status":"COMPLETED","sponsor":"Barinthus Biotherapeutics","startDate":"2019-02-10","conditions":"Hepatitis B, Healthy","enrollment":47},{"nctId":"NCT06879327","phase":"PHASE2","title":"Infant Malaria Vaccine Schedule Optimization","status":"RECRUITING","sponsor":"PATH","startDate":"2025-05-30","conditions":"Malaria Vaccines","enrollment":1200},{"nctId":"NCT07085715","phase":"","title":"Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain","status":"NOT_YET_RECRUITING","sponsor":"Fundació Institut Germans Trias i Pujol","startDate":"2025-10","conditions":"HIV, Hepatitis B, Hepatitis C","enrollment":500},{"nctId":"NCT04193189","phase":"PHASE3","title":"B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-12-14","conditions":"HIV Infection, Hepatitis B","enrollment":638},{"nctId":"NCT06947499","phase":"PHASE2, PHASE3","title":"A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series","status":"RECRUITING","sponsor":"LG Chem","startDate":"2025-05-30","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":1186},{"nctId":"NCT00505063","phase":"PHASE2","title":"Prospective Trial of Vaccine Responses in Childhood Cancer Survivors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-07-10","conditions":"Childhood Cancer, Multiple Diseases","enrollment":76},{"nctId":"NCT06998992","phase":"","title":"Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Individuals Born in France and Consulting at the CeGIDD in Saint-Denis.","status":"COMPLETED","sponsor":"Centre Hospitalier de Saint-Denis","startDate":"2020-07-01","conditions":"Hepatitis B, Vaccination, Health Knowledge, Attitudes, Practice","enrollment":200},{"nctId":"NCT06070051","phase":"PHASE1","title":"Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Virion Therapeutics","startDate":"2023-09-26","conditions":"Chronic Hepatitis B","enrollment":56},{"nctId":"NCT03343431","phase":"PHASE3","title":"Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recherche pour le Developpement","startDate":"2018-08-02","conditions":"Hepatitis B, Pregnancy","enrollment":504},{"nctId":"NCT02760537","phase":"NA","title":"Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2013-04","conditions":"Liver Neoplasms, Hepatitis B","enrollment":232},{"nctId":"NCT06888479","phase":"PHASE3","title":"Optimal Timing of Hepatitis B Vaccination After Transplants","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-06-01","conditions":"Transplant-Related Disorder, Hepatitis B Virus Infection, Vaccine Reaction","enrollment":1500},{"nctId":"NCT05272735","phase":"PHASE4","title":"HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers","status":"RECRUITING","sponsor":"Rockefeller University","startDate":"2022-12-10","conditions":"Hepatitis B","enrollment":12},{"nctId":"NCT06876467","phase":"","title":"Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-01","conditions":"Hepatitis B Vaccination, Immune Response, T Cells","enrollment":115},{"nctId":"NCT03566940","phase":"PHASE2","title":"A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2018-07-31","conditions":"Healthy","enrollment":302},{"nctId":"NCT06454812","phase":"NA","title":"The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-07-15","conditions":"Procedural Pain, Nursing Caries, Pain, Acute","enrollment":108},{"nctId":"NCT06748612","phase":"PHASE4","title":"Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)","status":"NOT_YET_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2025-01-28","conditions":"Polio","enrollment":1190},{"nctId":"NCT02868970","phase":"PHASE4","title":"Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction","status":"COMPLETED","sponsor":"Canadian Immunization Research Network","startDate":"2017-02-15","conditions":"Healthy","enrollment":2404},{"nctId":"NCT02942277","phase":"PHASE1","title":"Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-10-21","conditions":"Malaria","enrollment":301},{"nctId":"NCT04904835","phase":"","title":"Access HBV Assays - European Union (EU) Clinical Trial Protocol -","status":"RECRUITING","sponsor":"Beckman Coulter, Inc.","startDate":"2019-10-15","conditions":"HBV","enrollment":21210},{"nctId":"NCT05978037","phase":"PHASE1, PHASE2","title":"A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2023-08-18","conditions":"Malaria, Malaria,Falciparum, Parasitic Disease","enrollment":58},{"nctId":"NCT05787899","phase":"","title":"Hypothermia's Effect on Hepatitis B Vaccination","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2023-05-18","conditions":"Hypoxic-Ischemic Encephalopathy, Hepatitis B Vaccination, Hypothermia, Newborn","enrollment":9},{"nctId":"NCT06377748","phase":"NA","title":"The Effect of Facilitated-tucking and ShotBlocker on Pain Caused by Vaccination in Healthy Infants","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-06-15","conditions":"Procedural Pain, Pain, Acute, Nursing Caries","enrollment":142},{"nctId":"NCT06413121","phase":"PHASE3","title":"Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV","status":"RECRUITING","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2024-05-06","conditions":"Diptheria Immunization, Tetanus Immunization, Pertussis Immunization","enrollment":1557},{"nctId":"NCT04535037","phase":"PHASE4","title":"A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-05-26","conditions":"Diphtheria","enrollment":500},{"nctId":"NCT06515938","phase":"NA","title":"Study on New Strategies for Hepatitis B Virus Immunization","status":"COMPLETED","sponsor":"Wu Jiang","startDate":"2013-01-01","conditions":"Vaccine Reaction","enrollment":1169},{"nctId":"NCT04661579","phase":"PHASE2","title":"Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy","status":"COMPLETED","sponsor":"PATH","startDate":"2020-11-06","conditions":"Plasmodium Falciparum","enrollment":620},{"nctId":"NCT06180447","phase":"","title":"Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Xin","startDate":"2024-01-01","conditions":"Vaccine Adverse Reaction","enrollment":150000},{"nctId":"NCT06279169","phase":"NA","title":"The Effect of Heart Sound and White Noise on Pain and Physiological Parameters During Hepatitis B Vaccine Injection","status":"RECRUITING","sponsor":"Bartın Unıversity","startDate":"2024-04-24","conditions":"Pain, Acute, Newborn; Vitality","enrollment":99},{"nctId":"NCT06333275","phase":"","title":"Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-11-14","conditions":"Vaccine Immunity in CAR-T Cell Therapy Recipients","enrollment":80},{"nctId":"NCT02605538","phase":"NA","title":"Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively","status":"WITHDRAWN","sponsor":"Karolinska University Hospital","startDate":"2015-09-01","conditions":"Cystic Fibrosis, Hepatitis A, Hepatitis B","enrollment":""},{"nctId":"NCT01311674","phase":"PHASE3","title":"Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)","status":"TERMINATED","sponsor":"Emergent BioSolutions","startDate":"2009-09","conditions":"Healthy Volunteers","enrollment":141},{"nctId":"NCT06307808","phase":"","title":"Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination","status":"UNKNOWN","sponsor":"University Hospital, Grenoble","startDate":"2024-03-15","conditions":"HBV, Kidney Transplantation, Liver Transplantation","enrollment":66},{"nctId":"NCT06290726","phase":"","title":"Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2002-02","conditions":"Living Donor Liver Transplantations With Anti-HBc (+) Grafts","enrollment":204},{"nctId":"NCT05841095","phase":"PHASE1, PHASE2","title":"Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2023-08-04","conditions":"Chronic Hepatitis b","enrollment":24},{"nctId":"NCT03530124","phase":"PHASE4","title":"Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-07-17","conditions":"Apnea, Apnea Neonatal, Prematurity","enrollment":223},{"nctId":"NCT04519710","phase":"NA","title":"Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies","status":"COMPLETED","sponsor":"Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida","startDate":"2020-09-15","conditions":"HBV","enrollment":60},{"nctId":"NCT03459157","phase":"NA","title":"Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2017-11-20","conditions":"HIV/AIDS","enrollment":649},{"nctId":"NCT06213506","phase":"PHASE2","title":"A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-01-15","conditions":"Salmonella Infections","enrollment":516},{"nctId":"NCT06209398","phase":"PHASE4","title":"Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine","status":"UNKNOWN","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2018-05-24","conditions":"Hand, Foot and Mouth Disease","enrollment":510},{"nctId":"NCT06196502","phase":"NA","title":"The Effect of Gentle Human Touch and Kangaroo Care on Pain and Crying Physiological Parameters During Hepatitis-B Vaccination in a Newborn","status":"UNKNOWN","sponsor":"Kirsehir Ahi Evran Universitesi","startDate":"2024-02-01","conditions":"Pain","enrollment":80},{"nctId":"NCT06175520","phase":"NA","title":"Introduction of Preconception Care Through Public Health System for Improving MNCH&FP","status":"UNKNOWN","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2021-10-01","conditions":"Feasibility, Acceptability of Health Care","enrollment":2500},{"nctId":"NCT04029454","phase":"NA","title":"Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule","status":"COMPLETED","sponsor":"Institut Pasteur","startDate":"2020-10-19","conditions":"Hepatitis B","enrollment":10000},{"nctId":"NCT03246230","phase":"NA","title":"Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2017-09-06","conditions":"Newborn Vaccine Immunogenicity","enrollment":911},{"nctId":"NCT02693652","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine","status":"COMPLETED","sponsor":"CHA Vaccine Institute Co., Ltd.","startDate":"2014-10-28","conditions":"Hepatitis B, Chronic","enrollment":53},{"nctId":"NCT03632720","phase":"PHASE3","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-10-10","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":788},{"nctId":"NCT04780867","phase":"NA","title":"Psychological and Lifestyle Factors on Health Outcomes","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2020-10-19","conditions":"Psychological, Stress, Immune Health","enrollment":1188},{"nctId":"NCT06023056","phase":"","title":"Hepatitis B Vaccination After Neonatal Surgery","status":"RECRUITING","sponsor":"Children's Hospital of Chongqing Medical University","startDate":"2022-11-01","conditions":"Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn","enrollment":180},{"nctId":"NCT06029634","phase":"","title":"Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2020-07-01","conditions":"Chronic HBV Infection, Drug Withdrawal","enrollment":45},{"nctId":"NCT05967650","phase":"NA","title":"Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-09-01","conditions":"Inflammatory Bowel Diseases","enrollment":200},{"nctId":"NCT05200338","phase":"NA","title":"Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD","status":"UNKNOWN","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-06-08","conditions":"Sickle Cell Disease","enrollment":30},{"nctId":"NCT05002907","phase":"","title":"Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)","status":"COMPLETED","sponsor":"Centre Hospitalier de Cayenne","startDate":"2018-01-01","conditions":"Hepatitis B, Hepatitis C, Hepatitis D","enrollment":2289},{"nctId":"NCT05371743","phase":"","title":"Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2022-05-01","conditions":"Primary Immune Thrombocytopenia","enrollment":2},{"nctId":"NCT04303494","phase":"","title":"Predictive Value of Heart Rate Variability on Cardiorespiratory Events","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-07-01","conditions":"Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)","enrollment":292},{"nctId":"NCT03180359","phase":"NA","title":"Vaccines Immunogenicity in Renal, Hepatic, Cardiac or Pulmonary Transplanted Children","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2016-01-01","conditions":"Transplantation","enrollment":55},{"nctId":"NCT04939350","phase":"","title":"Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2021-09-27","conditions":"Cirrhosis","enrollment":742},{"nctId":"NCT03149874","phase":"NA","title":"Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2014-12-01","conditions":"Hepatitis B, Hemodialysis Complication","enrollment":114},{"nctId":"NCT04371276","phase":"","title":"Seroepidemiology of Viral Hepatitis in Hong Kong","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-09-01","conditions":"Viral Hepatitis","enrollment":2888},{"nctId":"NCT05481801","phase":"","title":"Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)","status":"COMPLETED","sponsor":"Castilla-La Mancha Health Service","startDate":"2022-09-01","conditions":"Type 1 Diabetes","enrollment":300},{"nctId":"NCT03620162","phase":"PHASE3","title":"A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-18","conditions":"Pneumococcal Infections","enrollment":900},{"nctId":"NCT04001322","phase":"NA","title":"Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS)","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2019-06-15","conditions":"Low Immunization Uptake","enrollment":21},{"nctId":"NCT01292421","phase":"NA","title":"Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2013-02","conditions":"Healthy, no Evidence of Disease","enrollment":""},{"nctId":"NCT02434848","phase":"PHASE2, PHASE3","title":"A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2015-07-23","conditions":"HIV, Communicable Diseases, Hepatitis B","enrollment":13},{"nctId":"NCT03951870","phase":"NA","title":"Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune Functioning","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2019-01-20","conditions":"Immune Hepatitis","enrollment":85},{"nctId":"NCT03240328","phase":"PHASE1","title":"The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function","status":"RECRUITING","sponsor":"Guangzhou 8th People's Hospital","startDate":"2017-10-04","conditions":"HIV/AIDS","enrollment":40},{"nctId":"NCT05523921","phase":"","title":"Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-09-01","conditions":"HBV Transmission","enrollment":50},{"nctId":"NCT04490499","phase":"PHASE3","title":"A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-09-02","conditions":"Hepatitis B","enrollment":207},{"nctId":"NCT04531098","phase":"PHASE3","title":"A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2006-03-02","conditions":"Hepatitis B","enrollment":402},{"nctId":"NCT03373656","phase":"NA","title":"Vaccination for Children of H&O and Their Parents","status":"UNKNOWN","sponsor":"Children's Cancer Group, China","startDate":"2017-05-01","conditions":"Vaccination, Hematologic Malignancy, Solid Tumor, Childhood","enrollment":300},{"nctId":"NCT04072211","phase":"PHASE4","title":"Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2019-11-25","conditions":"Hepatitis B Virus, Health Care Associated Infection","enrollment":641},{"nctId":"NCT03459521","phase":"NA","title":"Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2017-09-01","conditions":"Liver Disease Chronic, Hepatitis B Virus","enrollment":125},{"nctId":"NCT03985085","phase":"NA","title":"Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire","status":"UNKNOWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2019-11-26","conditions":"HIV Infections, Viral Hepatitis B, Sexually Transmitted Diseases","enrollment":500},{"nctId":"NCT04083157","phase":"PHASE2, PHASE3","title":"Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2019-08-12","conditions":"Inflammatory Bowel Diseases, Hepatitis B","enrollment":104},{"nctId":"NCT02697474","phase":"PHASE3","title":"Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2016-02","conditions":"Hepatitis B","enrollment":150},{"nctId":"NCT01049035","phase":"PHASE2","title":"A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-12-16","conditions":"Meningitis, Meningococcal Infection","enrollment":580},{"nctId":"NCT03829735","phase":"NA","title":"Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal","status":"WITHDRAWN","sponsor":"Institut Pasteur","startDate":"2020-11-01","conditions":"Hepatitis B","enrollment":""},{"nctId":"NCT05095844","phase":"","title":"National Vaccine Adverse Event Reporting Survey and Etiology","status":"UNKNOWN","sponsor":"Neuroganics LLC","startDate":"2022-03-15","conditions":"COVID-19, Vaccine Adverse Reaction, Vaccine Reaction","enrollment":100000},{"nctId":"NCT03316807","phase":"PHASE4","title":"Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults","status":"COMPLETED","sponsor":"Suping Wang","startDate":"2014-10","conditions":"Hepatitis B Vaccine","enrollment":182},{"nctId":"NCT02959775","phase":"PHASE4","title":"Immunogenicity of Hepatitis B Vaccination Among Drug Users","status":"COMPLETED","sponsor":"Shanxi Medical University","startDate":"2014-08","conditions":"Hepatitis B Vaccination","enrollment":480},{"nctId":"NCT02963714","phase":"PHASE4","title":"Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients","status":"COMPLETED","sponsor":"Suping Wang","startDate":"2014-12","conditions":"Hepatitis B Vaccine","enrollment":352},{"nctId":"NCT05172453","phase":"","title":"Mother-to-child Transmission of HBV in China","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2015-07-01","conditions":"Hepatitis B, Chronic, Mother to Child Transmission","enrollment":50000},{"nctId":"NCT02991599","phase":"PHASE4","title":"Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients","status":"COMPLETED","sponsor":"Shanxi Medical University","startDate":"2014-10","conditions":"Hepatitis B Vaccine","enrollment":196}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Euvax B Inj"],"phase":"marketed","status":"active","brandName":"HBV vaccination","genericName":"HBV vaccination","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"HBV vaccination stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus antigens, preventing infection and chronic disease. Used for Prevention of hepatitis B virus infection in infants, children, and adults, Post-exposure prophylaxis in non-immune individuals exposed to HBV.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}